Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial

Hemostemix (TSXV:HEM) is pleased to announce that it has received all approvals from three new medical centers to be clinical trial sites for the Company’s Phase II clinical trial for critical limb ischemia.  In addition, the Company is pleased to provide an update on patient enrollment in the trial.

As quoted in the press release:

Presbyterian Medical Center Novant Health Heart and Vascular Institute (“Novant”) is located in Charlotte, North Carolina with Dr. Michael Miller, MD, as the principal investigator.  Dr. Miller has been practicing for over 30 years and specializes in interventional cardiology and cardiovascular disease.  With 7,000 employees and over 700 physicians on medical staff, Novant is the one of the largest medical centers serving the Charlotte-Mecklenburg region. Charlotte is the largest city in North Carolina and the second largest city in the Southeastern United States. Almost 20% of its population is over the age of 55.  US Census Bureau noted the number of residents across the Charlotte-Concord-Gastonia region was approximately 2.5 million as of mid-2017.

Temple University Hospital (“TUH”), which is part of the Temple University Health System (“TUHS”) is ranked among the “Best Hospitals” in the region by U.S. News & World Report.  TUH is a 732-bed hospital located in Philadelphia, Pennsylvania.  TUH’s Temple Heart & Vascular Institute focuses on patient-centered care, research and education with more than 100 cardiovascular caregivers.  The principal investigator is Dr. Eric T. Choi, MD, who serves as the Co-Surgical Director, Temple Heart & Vascular Institute and his clinical interests include carotid artery disease and CLI.  Philadelphia is the state of Pennsylvania’s largest city and one of the largest cities on the east coast of the United States. 2017 U.S. Census Bureau data shows the Philadelphia metropolitan area, which also includes Wilmington, Camden and Philadelphia suburbs, had a population of over 6 million people, ranking it as the 8^th most populous metropolitan area in the entire United States.

Click here to read the full press release.